Skip to main content

Table 2 HPV results in mothers and infants included in the prospective cohort study.

From: Human Papillomavirus (HPV) infection in pregnant women and mother-to-child transmission of genital HPV genotypes: a prospective study in Spain

  Number
(n = 143)
% (95% CI)
Mothers' HPV-DNA status at pregnancy    
Positive/Tested 66/143 46.2 (37.8–54.7)
Type distribution among HPV positive:    
HPV 6,11 10 15.2  
HPV 16 17 25.8  
HPV 18 4 6.1  
HPV 31 1 1.5  
HPV 33 1 1.5  
HPV 39 1 1.5  
HPV 16 + other types 7 10.6  
HPV 31 + other types 5 7.6  
HPV 33 + other types 1 1.5  
HPV X 19 28.8  
Mothers' HPV-DNA prevalence at 6 weeks postpartum    
Positive/Tested 25/118 21.2 (14.2–29.7)
Type distribution among HPV positive:    
HPV 6,11 4 16.0  
HPV 16 8 32.0  
HPV 18 2 8.0  
HPV 16 + other types 2 8.0  
HPV 18 + other types 1 4.0  
HPV 31 + other types 2 8.0  
HPV 39 + other types 1 4.0  
HPV X 5 20.0  
Infants' HPV-DNA positivity (positive/tested)    
Between 0 and 6 days 7/117 6.0 (2.4–11.9)
6 weeks after birth 14/110 12.7 (7.1–20.4)
Between 3 and 24 months 8/88 9.1 (4.0–17.1)
At any point (0 to 24 months) 26/143 18.2 (12.2–25.5)
Type distribution among HPV positive (at any point during follow-up):    
HPV X 10 38.5  
HPV 16 8 30.8  
HPV 6/11 6 23.1  
HPV 18 1 3.8  
HPV 31 1 3.8  
Infants' HPV positivity by mother's HPV-DNA status (positive/tested)    
Born to HPV negative mothers 13/77 16.9 (9.3–27.1)
Born to HPV positive mothers 13/66 19.7 (10.9–31.3)
Origin of HPV positive samples in children    
Oral 16 51.6  
Genital 15 48.4